Valuation : Artivion, Inc.

Market Cap 1.32B 1.14B 1.07B 980M 1.83B 125B 1.84B 12.71B 4.93B 63.8B 4.96B 4.85B 210B P/E 2026 *
-97.6x
P/E 2027 * 91.2x
Enterprise Value 1.32B 1.14B 1.07B 980M 1.83B 125B 1.84B 12.71B 4.93B 63.8B 4.96B 4.85B 210B EV / Sales 2026 *
2.69x
EV / Sales 2027 * 2.43x
Free-Float
89.38%
Yield 2026 *
-
Yield 2027 * -
1 day-2.77%
1 week-0.15%
Current month-2.41%
1 month-1.83%
3 months+25.13%
6 months-31.58%
Current year-42.25%
1 week 25.86
Extreme 25.86
27.95
1 month 25.79
Extreme 25.7875
30.14
Current year 19.16
Extreme 19.16
46.84
1 year 19.16
Extreme 19.16
48.25
3 years 12.16
Extreme 12.1582
48.25
5 years 9.64
Extreme 9.64
48.25
10 years 9.64
Extreme 9.64
48.25
Manager TitleAgeSince
Chief Executive Officer 59 01/09/2014
Director of Finance/CFO 53 03/12/2023
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 71 30/11/2003
Director/Board Member 66 30/11/2003
Director/Board Member 61 30/04/2012
Date Insider Type Main position Quantity % Market Cap. Importance
19/08/26 Sell

Chief Executive Officer

-70,000 0.1442%
14/08/26 Sell

General Counsel

-616 0.0013%
14/08/26 Sell

Chief Financial Officer

-715 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-2.77%-0.15%-40.04%+51.29% 1.32B
+1.41%-4.87%-16.73%+7.41% 188B
+0.15%+1.14%-0.68%+12.24% 118B
+1.63%+2.53%+15.35%+92.25% 63.16B
-1.89%-2.30%+26.76%+50.42% 52.01B
+0.21%-1.19%-2.83%-32.66% 50.97B
-0.50%+0.59%+19.05%-11.98% 34.02B
+3.39%+1.85% - - 30.8B
+1.18%-1.68%+38.74%-15.96% 23.83B
-2.97%-4.91%-7.98%+11.64% 23.45B
Average +0.03%-1.22%+3.52%+18.29% 58.59B
Weighted average by Cap. +0.67%-2.59%+0.57%+16.53%

Financials

2026 *2027 *
Net sales 490M 423M 399M 364M 679M 46.57B 684M 4.72B 1.83B 23.69B 1.84B 1.8B 77.84B 543M 469M 442M 403M 752M 51.58B 758M 5.23B 2.03B 26.24B 2.04B 2B 86.22B
Net income -12.09M -10.43M -9.83M -8.96M -16.73M -1.15B -16.86M -116M -45.11M -584M -45.38M -44.39M -1.92B 14.8M 12.77M 12.03M 10.97M 20.49M 1.41B 20.64M 142M 55.23M 715M 55.56M 54.34M 2.35B
Net Debt - -
Logo Artivion, Inc.
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.
Employees
1,800
Date Price Change Volume
02/09/26 US$26.34 -2.77% 549,487
01/09/26 US$27.09 +0.37% 675,100
31/08/26 US$26.99 +0.82% 669,065
28/08/26 US$26.77 +0.37% 466,495
27/08/26 US$26.67 -1.95% 440,843
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
27.09USD
Average target price
42.15USD
Spread / Average Target
+55.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AORT Stock